Literature DB >> 911728

Treatment with urokinase.

.   

Abstract

Mesh:

Substances:

Year:  1977        PMID: 911728      PMCID: PMC1043025          DOI: 10.1136/bjo.61.8.499

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


× No keyword cloud information.
  5 in total

1.  Intravitreal fibrinolysis in experimental vitreous haemorrhage.

Authors:  J V Forrester; W Edgar; C R Prentice; C D Forbes; J Williamson
Journal:  Exp Eye Res       Date:  1976-02       Impact factor: 3.467

2.  Lytic therapy in vitreous haemorrhage.

Authors:  J V Forrester; J Williamson
Journal:  Trans Ophthalmol Soc U K       Date:  1974-07

3.  Intravitreal urokinase in the treatment of vitreous haemorrhage.

Authors:  P E Cleary; E W Davies; J S Shilling; A M Hamilton
Journal:  Trans Ophthalmol Soc U K       Date:  1974-07

4.  Intravitreal urokinase in the management of vitreous haemorrhage.

Authors:  P J Sellors; J J Kanski; D M Watson
Journal:  Trans Ophthalmol Soc U K       Date:  1974-07

5.  Intravitreal urokinase in the treatment of vitreous hemorrhage.

Authors:  W N Dugmore; M Raichand
Journal:  Am J Ophthalmol       Date:  1973-05       Impact factor: 5.258

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.